Bone erosion in RA is typified by the involvement of autoantibodies early in the disease as well as several inflammatory cytokines including TNF-α, IL-6, IL-1β and IL-17 which exert pro-osteoclastogenic effects via stimulation of production of RANKL and M-CSF (44–46). This evidence concerns the gene TNF and rheumatoid arthritis.